A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma

BACKGROUND: The majority of patients with hepatocellular carcinoma (HCC) are diagnosed in an advanced stage. Although sorafenib is recommended as the standard treatment for advanced HCC, its efficacy is limited. In some studies, hepatic arterial infusion chemotherapy has demonstrated a significant t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Leye, Lin, Junqing, Ke, Kun, Wu, Zhengzhong, Huang, Jingyao, Huang, Ning, Yang, Weizhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841468/
https://www.ncbi.nlm.nih.gov/pubmed/35261888
http://dx.doi.org/10.21037/tcr-21-1839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841468/
https://www.ncbi.nlm.nih.gov/pubmed/35261888
http://dx.doi.org/10.21037/tcr-21-1839

Ejemplares similares